Log in to search using one of your social media accounts:

 

Tolerability, persistence and satisfaction. Retrospective cohort study in patients with overactive bladder syndrome treated with transdermal Oxybutynin under Standard ClinicAl pRactice. OSCAR Study.

CONCLUSIONS: The study performed in patients with OAB shows that OXY-TDS provides low incidence of systemic adverse effects, including dry mouth, high persistence, improved adherence rates and high satisfaction of patients after one year of treatment. PMID: 28678009 [PubMed - in process]
Source: Archivos Espanoles de Urologia - Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research

Related Links:

Conclusions: Medication-specific dispensing rates for OAB changed when new alternatives became available. Recent changes in utilization and cost of OAB medications have implications for clinical guidelines, pharmacoepidemiologic studies, and payment policies.
Source: Medical Care - Category: Health Management Tags: Original Articles Source Type: research
Aims: To investigate the association of bladder cold sensation (BCS) during the ice water test (IWT) and pain perception when botulinum toxin injections (BTI) are administered into the bladder wall.Material and Methods: In 86 patients with idiopathic overactive bladder, the BCS during the IWT was investigated. Patients were divided into 2 groups: with and without BCS. During subsequent administration of BTI, the number of perceived and painful injections as well as the pain levels on a 0-100 pain scale were compared in both groups using Studentt test.Results: Thirty-five patients reported a BCS, while 51 did not. After 10 ...
Source: Urologia Internationalis - Category: Urology & Nephrology Source Type: research
This article is protected by copyright. All rights reserved.
Source: Basic and Clinical Pharmacology and Toxicology - Category: Drugs & Pharmacology Authors: Tags: Original Article Source Type: research
This article is protected by copyright. All rights reserved. PMID: 29345103 [PubMed - as supplied by publisher]
Source: Clinical Genitourinary Cancer - Category: Cancer & Oncology Authors: Tags: Basic Clin Pharmacol Toxicol Source Type: research
Conclusions: Medication-specific dispensing rates for OAB changed when new alternatives became available. Recent changes in utilization and cost of OAB medications have implications for clinical guidelines, pharmacoepidemiologic studies, and payment policies.
Source: Medical Care - Category: Health Management Tags: Original Articles Source Type: research
ConclusionsStudy subjects were able to charge the Axonics r‐SNM System and stimulation settings provided 2 weeks of therapy between recharging for most subjects. Subject satisfaction indicates that subjects are satisfied with rechargeable SNM therapy.
Source: Neurourology and Urodynamics - Category: Urology & Nephrology Authors: Tags: ORIGINAL CLINICAL ARTICLE Source Type: research
CONCLUSION: In our country, BoNTA injections for idiopathic overactive bladder are mainly effected after tibial neuromodulation or sacral neuromodulation failure. Diagnostic, operating and outcome evaluation practices are still very heterogeneous pleading for a greater standardization of this new therapy in this indication. LEVEL OF EVIDENCE: 3. PMID: 29329897 [PubMed - as supplied by publisher]
Source: Progres en Urologie - Category: Urology & Nephrology Tags: Prog Urol Source Type: research
ConclusionsThe range of direct healthcare costs reported for managing patients with OAB varied, but was relatively small given the differing contributing data sources, study designs, and cost definitions. Direct costs were consistently higher among patients with OAB versus non‐OAB comparisons, from a 1.4‐ to>2‐fold increase annually. OAB‐specific costs made up a small proportion of all‐cause costs, highlighting the clinical and economic impact of OAB‐related conditions such as falls, urinary tract infection, and depression. Few studies were identified that examined the indirect costs of OAB in the US.
Source: Neurourology and Urodynamics - Category: Urology & Nephrology Authors: Tags: REVIEW ARTICLE Source Type: research
Authors: Chung E, Lee D, Gani J, Gillman M, Maher C, Brennan J, Johns Putra L, Ahmad L, Chan LL Abstract INTRODUCTION: Overactive bladder (OAB) is a highly prevalent medical condition that has an adverse impact on various health-related quality-of-life domains, including a significant psychosocial and financial burden. This position statement, formulated by members of the Urological Society of Australia and New Zealand and the UroGynaecological Society of Australasia, summarises the current recommendations for clinical diagnosis and treatment strategies in patients with non-neurogenic OAB, and guides clinicians in ...
Source: Medical Journal of Australia - Category: General Medicine Tags: Med J Aust Source Type: research
Nearly 40% of older women and up to 35% of older men live with distressing urinary health conditions that can compromise quality of life and quality of care.1,2 Direct and indirect spending on just one of these conditions, overactive bladder, has crested $65 billion annually, according to some estimates.1 The social and economic toll of poor bladder health presents a significant barrier to optimizing the well-being of older adults and caregivers – so why do we see limited clinical practice and research information on these complex geriatric syndromes?2
Source: Geriatric Nursing - Category: Nursing Authors: Source Type: research
More News: Men | Overactive Bladder | Overactive Bladder Syndrome | Oxybutynin | Study | Urology & Nephrology | Women